// App-Quantinova.ai

Mo1178 : Risk of Lymphoma and Leukemia Among Inflammatory Bowel Disease Patients Using Immunomodulators: Population-Based Cohort Study

Researchers

Presenter

  • Siddharth Singh

Principal Investigators

  • Jithinraj Edakkanambeth Varayil

  • William S. Harmsen

  • William J. Tremaine

  • Laurent Peyrin-Biroulet

  • Edward V. Loftus

Medical Centers

  • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN

  • Division of Gastroenterology/Hepatology, Mayo Clinic, Rochester, MN

  • Hepato-Gastroenterology, University Hospital of Nancy, Vandoeuvre-les-Nancy, France

Locations

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Inflammatory bowel disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

  • Non-Hodgkin's Lymphoma

  • Hodgkin's Lymphoma

  • Ulcerative colitis

  • Non‐Hodgkin Lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved